Medera and Novoheart have collaborated with University of California San Diego School of Medicine and Mayo Clinic mini-heart ...

Acquisitions involving innovator drugs have grown year-on-year with total deal value increasing eight-fold to almost $18 ...

Revolution Medicines has partnered Royalty Pharma for $2bn to support development and commercialisation of its RAS(ON) ...

The US FDA has approved Sanofi and Regeneron’s Dupixent (dupilumab) as a treatment option for adults with bullous pemphigoid.

Membrane is a winner in the Innovation, Research & Development, and Environmental categories in the 2025 Pharmaceutical ...

Navamedic has signed an agreement for the acquisition of Norwegian company dne pharma in a deal valued at Nkr225m ($22m).

Novo Nordisk has ended a partnership with telehealth company Him & Hers, after launching the collaboration less than two ...

The FDA's new genAI-assisted scientific review technology, named Elsa, was officially adopted by the agency on 2 June.

The Pharmaceutical Technology Excellence Awards celebrate the greatest achievements and innovations in the industry. The programme provides a platform to recognize the people and companies that are ...

An EMA committee has recommended approval of Alvotech’s AVT06, a biosimilar to Bayer’s blockbuster ophthalmology drug Eylea.

Harbour BioMed has entered a strategic partnership with Otsuka focusing on the development of HBM7020 for treating autoimmune ...

Dedicated datasets highlight how social determinants of health can be used to improve overall standards of care.